Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11bhighGr1low macrophages
Gabriela Schiechl, … , Warren Strober, Stefan Fichtner-Feigl
Gabriela Schiechl, … , Warren Strober, Stefan Fichtner-Feigl
Published April 25, 2011
Citation Information: J Clin Invest. 2011;121(5):1692-1708. https://doi.org/10.1172/JCI42540.
View: Text | PDF
Research Article Article has an altmetric score of 3

Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11bhighGr1low macrophages

  • Text
  • PDF
Abstract

Patients with prolonged ulcerative colitis (UC) frequently develop colorectal adenocarcinoma for reasons that are not fully clear. To analyze inflammation-associated colonic tumorigenesis, we developed a chronic form of oxazolone-induced colitis in mice that, similar to UC, was distinguished by the presence of IL-13–producing NKT cells. In this model, the induction of tumors using azoxymethane was accompanied by the coappearance of F4/80+CD11bhighGr1low M2 macrophages, cells that undergo polarization by IL-13 and are absent in tumors that lack high level IL-13 production. Importantly, this subset of macrophages was a source of tumor-promoting factors, including IL-6. Similar to dextran sodium sulfate–induced colitis, F4/80+CD11bhighGr1intermediate macrophages were present in the mouse model of chronic oxazolone-induced colitis and may influence tumor development through production of TGF-β1, a cytokine that inhibits tumor immunosurveillance. Finally, while robust chronic oxazolone-induced colitis developed in myeloid differentiation primary response gene 88–deficient (Myd88–/–) mice, these mice did not support tumor development. The inhibition of tumor development in Myd88–/– mice correlated with cessation of IL-6 and TGF-β1 production by M2 and F4/80+CD11bhighGr1intermediate macrophages, respectively, and was reversed by exogenous IL-6. These data show that an UC-like inflammation may facilitate tumor development by providing a milieu favoring development of MyD88-dependent tumor-supporting macrophages.

Authors

Gabriela Schiechl, Bernhard Bauer, Ivan Fuss, Sven A. Lang, Christian Moser, Petra Ruemmele, Stefan Rose-John, Markus F. Neurath, Edward K. Geissler, Hans-Jürgen Schlitt, Warren Strober, Stefan Fichtner-Feigl

×

Figure 2

Cytokine expression and IL-6 dependency of AOM-induced tumors.

Options: View larger image (or click on image) Download as PowerPoint
Cytokine expression and IL-6 dependency of AOM-induced tumors.
(A) Cytok...
(A) Cytokine expression during chronic oxa-colitis and chronic oxa-colitis with AOM-induced tumors. Cells were extracted from the lamina propria and stimulated for 48 hours. Cytokine concentrations were determined in culture supernatants by ELISA. Data shown are mean ± SEM from individual cultures of cells derived from mice in 2 separate experiments (n = 6 mice per group). *P ≤ 0.05. (B) Body weight after treatment with anti–IL-6 antibody. Data shown are mean ± SEM (n = 6 mice per group). (C) H&E staining of representative inflamed areas of colon sections (original magnification, ×10) and histology score on day 49 of oxa-colitis with AOM-induced tumors following treatment with anti–IL-6 antibody. Horizontal bars are mean values (n = 6 mice per group). Individual symbols represent 1 mouse. (D) IL-13 production on day 49 of oxa-colitis and oxa-colitis with AOM-induced tumors after treatment with anti–IL-6 antibody. Cells were extracted from the lamina propria on day 49. Cytokine concentrations were determined in culture supernatants by ELISA. Data shown are mean ± SEM from individual cultures of cells derived from mice in 2 separate experiments (n = 6 mice per group). *P ≤ 0.05. (E) Number of tumor nodules on day 49 of oxa-colitis with AOM-induced tumors after treatment with anti–IL-6 antibody. Horizontal bars are mean values (n = 6 mice per group). Individual symbols represent 1 mouse. *P ≤ 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
88 readers on Mendeley
See more details